Botanical species · safety record

Anadenanthera colubrina

The EFSA Compendium of Botanicals holds 11 constituent measurements and 2 adverse-effect records for Anadenanthera colubrina. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Anadenanthera colubrina (Vell.) Brenan

11Constituent measurements
2Safety records
7Cited sources
0Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Tannins7
  • Bufotenine3
  • Hydrocyanic acid1

Plant parts

  • Bark4
  • Seed4
  • Leaves3
  • Aerial part of plants2

Preparations

  • Solvent extraction9
  • Fresh1

Effect types

  • Neurotoxicity1
  • Systemic1

Target tissues

  • Neurologic: central nervous system1
  • Respiratory1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
TanninsAerial part of plantsSolvent extraction≥ 3 PercentClassification not possibleResolve DOI
TanninsAerial part of plantsSolvent extraction≤ 10 PercentClassification not possibleResolve DOI
TanninsBarkSolvent extractionTraditional analytical techniques (wet chemical tests)Resolve DOI
TanninsLeavesSolvent extractionTraditional analytical techniques (wet chemical tests)Resolve DOI
BufotenineSeedSolvent extraction2 PercentNuclear Magnetic Resonance (NMR)No resolvable identifier
BufotenineSeed0.5 PercentColorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier
BufotenineSeedSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
Hydrocyanic acidLeavesFreshPhytochemical screeningNo resolvable identifier
TanninsBarkSolvent extraction≥ 18 PercentNo resolvable identifier
TanninsBark15.4 PercentTraditional analytical techniques (wet chemical tests)No resolvable identifier
TanninsBarkSolvent extraction≤ 35 PercentNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
NeurotoxicityNeurologic: central nervous systemSeedSolvent extractionHuman (as organism)Study with volunteersNo resolvable identifier
SystemicRespiratoryLeavesCattle (as animal)Acute toxicityNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Monteiro, J�lio M., Albuquerque, Ulysses P., Lins Neto, Ernani M.F., Ara�jo, Elcida L., Albuquerque, Miracy M., Amorim, Elba L.C. The effects of seasonal climate changes in the caatinga on tannin levels in Myracrodruon urundeuva (Engl.) Fr. All. and Anadenanthera colubrina (Vell.) Brenan . Revista brasileira de farmacognosia, 2006, vol. 16, no. 3, p. 338-344. DOI
  2. Vigerelli Hugo., Sciani Juliana Mozer., Pimenta Daniel C., Jared Carlos., Antoniazzi Marta Maria., Caporale Graciane Maria Medeiros., da Silva Andrea de Cassia Rodrigues. Bufotenine is able to block rabies virus infection in BHK-21 cells. The journal of venomous animals and toxins including tropical diseases, 2014, vol. 20, no. 1, p. 45.
  3. Rendon P., Willy J. Isolation of bufotenine from seeds of the Piptadenia macrocarpa Benth.. Revista boliviana de quimica, 1985, vol. 5, no. 1, p. 39-43.
  4. Ott, J. Pharmanopo-psychonautics: Human intranasal, sublingual, intrarectal, pulmonary and oral pharmacology of bufotenine . Journal of psychoactive drugs, 2001, vol. 33, no. 3, p. 273-281.
  5. Tokarnia, Carlos Hubinger., Peixoto, Paulo Vargas., Dobereiner, Jurgen. Experimental poisoning by Piptadenia macrocarpa (Leg. Mimosoideae) in bovines . Pesquisa veterinaria brasileira, 1994, vol. 14, no. 2-3, p. 57-63.
  6. Paes, Juarez Benigno., Franco Diniz, Carlos Estevam., de Lima, Carlos Roberto., Bastos, Paulo de Melo., de Medeiros Neto, Pedro Nico. CONDENSED TANNINS OF Anadenanthera colubrina VAR. cebil BARK EXTRACTED WITH SODIUM HYDROXIDE AND SODIUM SULFITE SOLUTIONS . Revista caatinga, 2013, vol. 26, no. 3, p. 22-27.
  7. Prado, Luis L., Ricci, Enzo. Systematic study of the tannin content of various indigenous species.. Zzz, 1956, p. 7-17.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue